サマリー

Marine biodiversity is a rich source of medicines and natural products, potentially exploitable in the blue biotech industry The marine environment is our ocean of opportunity for new materials, new compounds and new processes for our society.
The research and industrialization of marine biomedicine is a key development area of the world's major maritime countries. Since the beginning of the 21st century, the development and listing of marine drugs has accelerated significantly. From 2000 to 2018, eight marine biopharmaceuticals have been supervised by the US Food and Drug Administration. The Authority or the European Medicines Evaluation Agency approved the listing. The global industrialization of marine biomedicine has accelerated.

Market Analysis and Insights: Global Marine Biomedicine Market
The global Marine Biomedicine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Marine Biomedicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Marine Biomedicine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Marine Biomedicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Marine Biomedicine market.

Global Marine Biomedicine Scope and Market Size
Marine Biomedicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Marine Biomedicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Marine Animal Technolog
Marine Plant Technology

Segment by Application
Drug
Health Care Products

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Marinova
NEB
BiotechMarine
GlycoMar
Marine Biotech
Nofima
Sams
Aquapharm

ページTOPに戻る

目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Marine Biomedicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Marine Animal Technolog
1.2.3 Marine Plant Technology
1.3 Market by Application
1.3.1 Global Marine Biomedicine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Drug
1.3.3 Health Care Products
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Marine Biomedicine Market Perspective (2016-2027)
2.2 Marine Biomedicine Growth Trends by Regions
2.2.1 Marine Biomedicine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Marine Biomedicine Historic Market Share by Regions (2016-2021)
2.2.3 Marine Biomedicine Forecasted Market Size by Regions (2022-2027)
2.3 Marine Biomedicine Industry Dynamic
2.3.1 Marine Biomedicine Market Trends
2.3.2 Marine Biomedicine Market Drivers
2.3.3 Marine Biomedicine Market Challenges
2.3.4 Marine Biomedicine Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Marine Biomedicine Players by Revenue
3.1.1 Global Top Marine Biomedicine Players by Revenue (2016-2021)
3.1.2 Global Marine Biomedicine Revenue Market Share by Players (2016-2021)
3.2 Global Marine Biomedicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Marine Biomedicine Revenue
3.4 Global Marine Biomedicine Market Concentration Ratio
3.4.1 Global Marine Biomedicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Marine Biomedicine Revenue in 2020
3.5 Marine Biomedicine Key Players Head office and Area Served
3.6 Key Players Marine Biomedicine Product Solution and Service
3.7 Date of Enter into Marine Biomedicine Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Marine Biomedicine Breakdown Data by Type
4.1 Global Marine Biomedicine Historic Market Size by Type (2016-2021)
4.2 Global Marine Biomedicine Forecasted Market Size by Type (2022-2027)

5 Marine Biomedicine Breakdown Data by Application
5.1 Global Marine Biomedicine Historic Market Size by Application (2016-2021)
5.2 Global Marine Biomedicine Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Marine Biomedicine Market Size (2016-2027)
6.2 North America Marine Biomedicine Market Size by Type
6.2.1 North America Marine Biomedicine Market Size by Type (2016-2021)
6.2.2 North America Marine Biomedicine Market Size by Type (2022-2027)
6.2.3 North America Marine Biomedicine Market Size by Type (2016-2027)
6.3 North America Marine Biomedicine Market Size by Application
6.3.1 North America Marine Biomedicine Market Size by Application (2016-2021)
6.3.2 North America Marine Biomedicine Market Size by Application (2022-2027)
6.3.3 North America Marine Biomedicine Market Size by Application (2016-2027)
6.4 North America Marine Biomedicine Market Size by Country
6.4.1 North America Marine Biomedicine Market Size by Country (2016-2021)
6.4.2 North America Marine Biomedicine Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Marine Biomedicine Market Size (2016-2027)
7.2 Europe Marine Biomedicine Market Size by Type
7.2.1 Europe Marine Biomedicine Market Size by Type (2016-2021)
7.2.2 Europe Marine Biomedicine Market Size by Type (2022-2027)
7.2.3 Europe Marine Biomedicine Market Size by Type (2016-2027)
7.3 Europe Marine Biomedicine Market Size by Application
7.3.1 Europe Marine Biomedicine Market Size by Application (2016-2021)
7.3.2 Europe Marine Biomedicine Market Size by Application (2022-2027)
7.3.3 Europe Marine Biomedicine Market Size by Application (2016-2027)
7.4 Europe Marine Biomedicine Market Size by Country
7.4.1 Europe Marine Biomedicine Market Size by Country (2016-2021)
7.4.2 Europe Marine Biomedicine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Marine Biomedicine Market Size (2016-2027)
8.2 Asia-Pacific Marine Biomedicine Market Size by Type
8.2.1 Asia-Pacific Marine Biomedicine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Marine Biomedicine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Marine Biomedicine Market Size by Type (2016-2027)
8.3 Asia-Pacific Marine Biomedicine Market Size by Application
8.3.1 Asia-Pacific Marine Biomedicine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Marine Biomedicine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Marine Biomedicine Market Size by Application (2016-2027)
8.4 Asia-Pacific Marine Biomedicine Market Size by Region
8.4.1 Asia-Pacific Marine Biomedicine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Marine Biomedicine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Marine Biomedicine Market Size (2016-2027)
9.2 Latin America Marine Biomedicine Market Size by Type
9.2.1 Latin America Marine Biomedicine Market Size by Type (2016-2021)
9.2.2 Latin America Marine Biomedicine Market Size by Type (2022-2027)
9.2.3 Latin America Marine Biomedicine Market Size by Type (2016-2027)
9.3 Latin America Marine Biomedicine Market Size by Application
9.3.1 Latin America Marine Biomedicine Market Size by Application (2016-2021)
9.3.2 Latin America Marine Biomedicine Market Size by Application (2022-2027)
9.3.3 Latin America Marine Biomedicine Market Size by Application (2016-2027)
9.4 Latin America Marine Biomedicine Market Size by Country
9.4.1 Latin America Marine Biomedicine Market Size by Country (2016-2021)
9.4.2 Latin America Marine Biomedicine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Marine Biomedicine Market Size (2016-2027)
10.2 Middle East & Africa Marine Biomedicine Market Size by Type
10.2.1 Middle East & Africa Marine Biomedicine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Marine Biomedicine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Marine Biomedicine Market Size by Type (2016-2027)
10.3 Middle East & Africa Marine Biomedicine Market Size by Application
10.3.1 Middle East & Africa Marine Biomedicine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Marine Biomedicine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Marine Biomedicine Market Size by Application (2016-2027)
10.4 Middle East & Africa Marine Biomedicine Market Size by Country
10.4.1 Middle East & Africa Marine Biomedicine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Marine Biomedicine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Marinova
11.1.1 Marinova Company Details
11.1.2 Marinova Business Overview
11.1.3 Marinova Marine Biomedicine Introduction
11.1.4 Marinova Revenue in Marine Biomedicine Business (2016-2021)
11.1.5 Marinova Recent Development
11.2 NEB
11.2.1 NEB Company Details
11.2.2 NEB Business Overview
11.2.3 NEB Marine Biomedicine Introduction
11.2.4 NEB Revenue in Marine Biomedicine Business (2016-2021)
11.2.5 NEB Recent Development
11.3 BiotechMarine
11.3.1 BiotechMarine Company Details
11.3.2 BiotechMarine Business Overview
11.3.3 BiotechMarine Marine Biomedicine Introduction
11.3.4 BiotechMarine Revenue in Marine Biomedicine Business (2016-2021)
11.3.5 BiotechMarine Recent Development
11.4 GlycoMar
11.4.1 GlycoMar Company Details
11.4.2 GlycoMar Business Overview
11.4.3 GlycoMar Marine Biomedicine Introduction
11.4.4 GlycoMar Revenue in Marine Biomedicine Business (2016-2021)
11.4.5 GlycoMar Recent Development
11.5 Marine Biotech
11.5.1 Marine Biotech Company Details
11.5.2 Marine Biotech Business Overview
11.5.3 Marine Biotech Marine Biomedicine Introduction
11.5.4 Marine Biotech Revenue in Marine Biomedicine Business (2016-2021)
11.5.5 Marine Biotech Recent Development
11.6 Nofima
11.6.1 Nofima Company Details
11.6.2 Nofima Business Overview
11.6.3 Nofima Marine Biomedicine Introduction
11.6.4 Nofima Revenue in Marine Biomedicine Business (2016-2021)
11.6.5 Nofima Recent Development
11.7 Sams
11.7.1 Sams Company Details
11.7.2 Sams Business Overview
11.7.3 Sams Marine Biomedicine Introduction
11.7.4 Sams Revenue in Marine Biomedicine Business (2016-2021)
11.7.5 Sams Recent Development
11.8 Aquapharm
11.8.1 Aquapharm Company Details
11.8.2 Aquapharm Business Overview
11.8.3 Aquapharm Marine Biomedicine Introduction
11.8.4 Aquapharm Revenue in Marine Biomedicine Business (2016-2021)
11.8.5 Aquapharm Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details